Fig. 3From: Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition“Hepatic Fibrosis/Hepatic Stellate Cell Activation” was the most significant canonical pathways modulated by Crenigacestat in iCCA PDX mouse modelsBack to article page